- Zacks•4 days ago
Vanda Pharmaceuticals (VNDA) has seen positive earnings estimate revisions for the current quarter and year, in addition to decent short-term price momentum.
- PR Newswire•11 days ago
WASHINGTON, Oct. 12, 2016 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced it will release results for the third quarter of 2016 on Wednesday, November 2, 2016, after the ...
- Benzinga•17 days ago
While Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ) have appreciated 38 percent since the favorable U.S. Fanapt IP ruling on August 25, Jefferies’ Matthew J. Andrews believes that there could be potential ...
Vanda Pharmaceuticals, Inc. (VNDA)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Bid||15.15 x 1000|
|Ask||17.89 x 700|
|Day's Range||15.75 - 16.08|
|52wk Range||6.91 - 18.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-16.47|
|Avg Vol (3m)||838,748|
|Dividend & Yield||N/A (N/A)|